<DOC>
	<DOCNO>NCT00703313</DOCNO>
	<brief_summary>The primary objective study compare concentration human tear levofloxacin active comparators 15 minute , 2,6 , 12 , 24 hour instillation single drop medication .</brief_summary>
	<brief_title>Ocular Availability Human Tears After Topical Administration 1.5 % Levofloxacin Compared Active Comparators</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Gatifloxacin</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Be willing able provide write informed consent HIPAA indicate understand purpose procedure require study willing participate study Be willing able follow instruction attend study visit If female childbearing potential , pregnant , nurse planning pregnancy agree submit pregnancy test . The result test must negative female subject childbearing potential must also agree use acceptable method contraception duration study ( acceptable method contraception include oral , implantable , transdermal , injectible contraceptive , spermicide barrier , IUD , surgical sterilization partner ) Have know allergy and/or sensitivity test article ( ) component therapy associate study Have active sign symptom clinically significant ocular disorder ( refractive disorder ) Have history dry eye syndrome Use disallow medication ( systemic topical ) ( i.e . fluoroquinolone antiinfective agent topical ophthalmic product ) appropriate prestudy washout period study . Be contact lens wearer unwilling forego contact lens wear within 3 day prior start study duration study Have ocular surgical intervention 12 month prior study anticipate ocular surgery study Be pregnant nursing woman ; woman positive urine pregnancy test screen woman childbearing potential refuse use adequate hormonal mechanical mean birth control Be concurrently enrol investigational drug device study use investigational drug device within 30 day entry study Employees investigator study center , direct involvement th propose study study direction investigator study center , well family member employee investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Study drug concentration human tear</keyword>
</DOC>